These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 37450492

  • 1. Two Cases of Chronic Central Serous Chorioretinopathy Successfully Treated with Systemic Interferon Alpha.
    Huang L, Flaxel C, Suhler E, Lin P.
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1465-1474. PubMed ID: 37450492
    [Abstract] [Full Text] [Related]

  • 2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A, Kneba M, Grzybowski A.
    BMC Ophthalmol; 2019 Jul 25; 19(1):160. PubMed ID: 31345183
    [Abstract] [Full Text] [Related]

  • 3. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
    Demirok G, Kocamaz F, Topalak Y, Altay Y, Sengun A.
    Int Ophthalmol; 2017 Apr 25; 37(2):409-416. PubMed ID: 27324370
    [Abstract] [Full Text] [Related]

  • 4. The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy.
    Karagiannis D, Parikakis E, Kontomichos L, Batsos G, Chatziralli I.
    Semin Ophthalmol; 2019 Apr 25; 34(6):436-441. PubMed ID: 31309849
    [Abstract] [Full Text] [Related]

  • 5. Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Gulkas S, Sahin O.
    Eur J Ophthalmol; 2020 Sep 25; 30(5):1053-1060. PubMed ID: 31256613
    [Abstract] [Full Text] [Related]

  • 6. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
    Wuarin R, Kakkassery V, Consigli A, Roquelaure D, Papanastasiou A, Schutz JS, Thumann G, Chronopoulos A.
    Optom Vis Sci; 2019 Jul 25; 96(7):500-506. PubMed ID: 31274738
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Efficacy and Safety of Photodynamic Therapy in Patients With Chronic Central Serous Chorioretinopathy.
    Park YJ, Kim YK, Park KH, Woo SJ.
    Ophthalmic Surg Lasers Imaging Retina; 2019 Dec 01; 50(12):760-770. PubMed ID: 31877221
    [Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
    Silva RM, Ruiz-Moreno JM, Gomez-Ulla F, Montero JA, Gregório T, Cachulo ML, Pires IA, Cunha-Vaz JG, Murta JN.
    Retina; 2013 Feb 01; 33(2):309-15. PubMed ID: 23095766
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Masqueraders of central serous chorioretinopathy.
    Sahoo NK, Singh SR, Rajendran A, Shukla D, Chhablani J.
    Surv Ophthalmol; 2019 Feb 01; 64(1):30-44. PubMed ID: 30243734
    [Abstract] [Full Text] [Related]

  • 11. Fluorescein angiography-guided photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy.
    Koytak A, Erol K, Coskun E, Asik N, Öztürk H, Özertürk Y.
    Retina; 2010 Feb 01; 30(10):1698-703. PubMed ID: 20539254
    [Abstract] [Full Text] [Related]

  • 12. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V, Vysloužilová D, Uher M.
    Semin Ophthalmol; 2018 Feb 01; 33(5):690-699. PubMed ID: 29252091
    [Abstract] [Full Text] [Related]

  • 13. A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Lai FH, Ng DS, Bakthavatsalam M, Chan VC, Young AL, Luk FO, Tsang CW, Brelén ME.
    Am J Ophthalmol; 2016 Oct 01; 170():91-99. PubMed ID: 27519561
    [Abstract] [Full Text] [Related]

  • 14. Discrepancy in current central serous chorioretinopathy classification.
    Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.
    Br J Ophthalmol; 2019 Jun 01; 103(6):737-742. PubMed ID: 30002069
    [Abstract] [Full Text] [Related]

  • 15. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
    Smretschnig E, Ansari-Shahrezaei S, Moussa S, Glittenberg C, Krebs I, Binder S.
    Retina; 2012 Jun 01; 32(10):2014-9. PubMed ID: 22466482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.